Evidence map›Paper›PMID 26588041›Full record

ArticleJournal of cellular physiology2016

Nuclear Factor κB1/RelA Mediates Inflammation in Human Lung Epithelial Cells at Atmospheric Oxygen Levels.

Lakshmanan Jagannathan, Cynthia C Jose, Adriana Arita, Thomas Kluz, Hong Sun, Xiaoru Zhang, Yixin Yao, Andrey V Kartashov, Artem Barski, Max Costa and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Lakshmanan JagannathanDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Cynthia C JoseDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Adriana AritaDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Thomas KluzDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Hong SunDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Xiaoru ZhangDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Yixin YaoDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Andrey V KartashovDivision of Allergy and Immunology and Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Artem BarskiDivision of Allergy and Immunology and Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Max CostaDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
Suresh CuddapahDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York.
New York University · USCincinnati Children's Hospital Medical Center · USUniversity of Cincinnati Medical Center · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
Direct Epigenetic Reprogramming of T CellsDP2GM119134 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI BARSKI, ARTEM · 2015 to 2015
$2.3M
SATB2 and Nickel CarcingenesisR01ES022935 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 2014 to 2018
$2.1M
Epigenetic Dysregulation by Oxidative Stress from Environmental InsultsR01ES023174 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX, CUDDAPAH, SURESH · 2013 to 2016
$2.0M
Epigenetic reprogramming by nickel through chromatin domain disruptionR01ES024727 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CUDDAPAH, SURESH · 2015 to 2019
$1.9M
NCATS NIH HHS UL1 TR001425NCI NIH HHS P30 CA016087NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P30ES000260NIEHS NIH HHS R01 ES022935NIEHS NIH HHS R01ES022935NIEHS NIH HHS R01 ES023174NIEHS NIH HHS R01ES023174NIEHS NIH HHS R01 ES024727NIEHS NIH HHS R01ES024727NIGMS NIH HHS DP2 GM119134
6 · The paper itself

Abstract

Oxygen levels range from 2% to 9% in vivo. Atmospheric O2 levels (21%) are known to induce cell proliferation defects and cellular senescence in primary cell cultures. However, the mechanistic basis of the deleterious effects of higher O2 levels is not fully understood. On the other hand, immortalized cells including cancer cell lines, which evade cellular senescence are normally cultured at 21% O2 and the effects of higher O2 on these cells are understudied. Here, we addressed this problem by culturing immortalized human bronchial epithelial (BEAS-2B) cells at ambient atmospheric, 21% O2 and lower, 10% O2. Our results show increased inflammatory response at 21% O2 but not at 10% O2. We found higher RelA binding at the NF-κB1/RelA target gene promoters as well as upregulation of several pro-inflammatory cytokines in cells cultured at 21% O2. RelA knockdown prevented the upregulation of the pro-inflammatory cytokines at 21% O2, suggesting NF-κB1/RelA as a major mediator of inflammatory response in cells cultured at 21% O2. Interestingly, unlike the 21% O2 cultured cells, exposure of 10% O2 cultured cells to H2O2 did not elicit inflammatory response, suggesting increased ability to tolerate oxidative stress in cells cultured at lower O2 levels.

Indexed as

Cell ProliferationCellular SenescenceCytokinesEpithelial CellsGene Knockdown TechniquesHumansInflammationLungOxygenPromoter Regions, GeneticTranscription Factor RelACytokinesOxygenRELA protein, humanTranscription Factor RelA

Identifiers

PMID26588041
PMCPMC4845657
OpenAlexW2257230718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.